New Perspectives in the Management of Secondary Hyperparathyroidism

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|7|6|591-598

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.7, Iss.6, 2007-06, pp. : 591-598

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paricalcitol: A Review of its Use in the Management of Secondary Hyperparathyroidism

By Dean M. Robinson   Lesley J. Scott  

Drugs, Vol. 65, Iss. 4, 2005-01 ,pp. : 559-576

Adis International

Access to resources Recommend Favorite

Management of Secondary Hyperparathyroidism in the Elderly Patient with Chronic Kidney Disease

By Cozzolino Mario   Gallieni Maurizio   Pasho Sabina   Fallabrino Giuditta   Ciceri Paola   >   Olivi Laura   Brancaccio Diego  

Drugs & Aging, Vol. 26, Iss. 6, 2009-06 ,pp. : 457-468

Adis International

Access to resources Recommend Favorite

Cinacalcet HCl: a calcimimetic agent for the management of primary and secondary hyperparathyroidism

By Franceschini Nora   Joy Melanie S   Kshirsagar Abhijit  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 8, 2003-08 ,pp. : 1413-1421

Informa Healthcare

Access to resources Recommend Favorite

IV paricalcitol the clear winner in secondary hyperparathyroidism

By  

Inpharma, Vol. 1, Iss. 1568, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Zoledronic acid: Hypocalcaemia and secondary hyperparathyroidism: case report

By  

Reactions Weekly, Vol. 1, Iss. 1333, 2011-01 ,pp. : 39-39

Adis International

Access to resources Recommend Favorite